DIMENSIONAL FUND ADVISORS LP

Position in OABIW — OmniAb, Inc.

CIK 354204 AUSTIN, TX

Position in OABIW

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

+$0 QoQ

Shares Held

1,262,099

-27.7% QoQ

Ownership

0.868%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 81% Shared 10% None 9%

Healthcare · as of Jun 30, 2026

DIMENSIONAL FUND ADVISORS LP holds $6,102,677,105 across 230 Biotechnology names. OABIW ranks #230 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,168,956	$580,655,511
2	JAZZ	Jazz Pharmaceuticals plc	1,713,592	$412,924,262
3	REGN	Regeneron Pharmaceuticals, Inc.	559,687	$348,987,230
4	INCY	Incyte Corp	2,280,803	$258,551,825
5	EXEL	Exelixis, Inc.	4,426,620	$240,852,392
6	BMRN	Biomarin Pharmaceutical Inc	4,075,714	$233,212,353
7	ROIV	Roivant Sciences Ltd.	5,230,417	$185,104,455
8	KRYS	Krystal Biotech, Inc.	476,038	$176,929,041

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	—	1,262,099	-27.7%	Shares	Sole	2026-08-11
2026-03-31	—	1,745,248	-18.9%	Shares	Sole	2026-05-07
2025-12-31	—	2,152,593	-15.5%	Shares	Sole	2026-02-12
2025-09-30	—	2,548,284	-12.5%	Shares	Sole	2025-11-12
2025-06-30	—	2,913,764	-7.0%	Shares	Sole	2025-08-12
2025-03-31	—	3,131,718	+3.5%	Shares	Sole	2025-05-13
2024-12-31	—	3,025,674	+4.9%	Shares	Sole	2025-02-13
2024-09-30	—	2,883,161	-4.3%	Shares	Sole	2024-11-07
2024-06-30	—	3,012,216	+6.9%	Shares	Sole	2024-08-09
2024-03-31	—	2,817,381	+7.4%	Shares	Sole	2024-05-10
2023-12-31	—	2,623,995	+12.6%	Shares	Sole	2024-02-07
2023-09-30	—	2,330,321	+36.5%	Shares	Sole	2023-11-09
2023-06-30	—	1,707,453	-11.8%	Shares	Sole	2023-08-09
2023-03-31	—	1,934,861	-3.9%	Shares	Sole	2023-05-12
2022-12-31	—	2,012,714	—	Shares	Sole	2023-02-09
No filing history on record for this holder in this stock.